Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Gynecology

Free Subscription 15.12.2025 4 Acta Obstet Gynecol Scand 11 Am J Obstet Gynecol 1 Am J Surg Pathol 2 Ann Oncol 1 Aust N Z J Obstet Gynaecol 2 BMC Cancer 1 BMC Urol 1 Br J Radiol 1 Cancer Res 1 Clin Cancer Res 1 Diagn Cytopathol 2 Eur J Cancer 10 Eur J Obstet Gynecol Reprod Biol 1 Fertil Steril 3 Gynecol Endocrinol 22 Gynecol Oncol 3 Hum Pathol 1 Int J Cancer 11 Int J Gynaecol Obstet 2 Int J Oncol 1 J Clin Endocrinol Metab 3 JAMA 2 Lancet 6 Obstet Gynecol 1 Oncogene 1 PLoS Med 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Obstet Gynecol Scand

1. ZEKERT HF, Biermann AL, Dutemeyer V, Meier N, et al
   Longitudinal maternal hemodynamics from late pregnancy to postpartum in uncomplicated twin pregnancies-A glimpse into long-term cardiovascular risk?
   Acta Obstet Gynecol Scand. 2025 Dec 12. doi: 10.1111/aogs.70120.
   PubMed         Abstract available
   
   
2. FRISCH IK, Michelsen TM, Lekva T, Roland MCP, et al
   Adhesion molecules in the maternal-fetal interface in healthy pregnancies and preeclampsia.
   Acta Obstet Gynecol Scand. 2025 Dec 12. doi: 10.1111/aogs.70111.
   PubMed         Abstract available
   
   
3. CHEN W, Xuan X
   Methodological concerns in the feasibility study on ultrasound pelvimetry for breech birth.
   Acta Obstet Gynecol Scand. 2025 Dec 8. doi: 10.1111/aogs.70118.
   PubMed        
   
   
4. LINDSTROM L, Stephansson O, Cnattingius S, Wilcox A, et al
   Fetal biometry and maternal characteristics for second trimester prediction of stillbirth.
   Acta Obstet Gynecol Scand. 2025 Dec 4. doi: 10.1111/aogs.70112.
   PubMed         Abstract available
   
   

   
   Am J Obstet Gynecol

5. RICHARDSON D, Lim CS, Liu Y, Morgan DM, et al
   Identifying potentially modifiable risk factors associated with racially disparate postoperative outcomes following benign hysterectomy.
   Am J Obstet Gynecol. 2025 Dec 2:S0002-9378(25)00872.
   PubMed         Abstract available
   
   
6. MEYER R, Hamilton KM, Ezike O, Ciesielski K, et al
   Vaginal hysterectomy vs laparoscopic hysterectomy for benign indications: complications and length of stay in a national analysis of contemporary data.
   Am J Obstet Gynecol. 2025 Oct 24:S0002-9378(25)00776.
   PubMed         Abstract available
   
   
7. CHEN S, Xu W, Zhang L, Luan X, et al
   Corrigendum to 'Expanded noninvasive prenatal screening for dominant single-gene disorders: proof-of-concept, performance, and challenges' American Journal of Obstetrics & Gynecology (2025) 233/6 [673-674].
   Am J Obstet Gynecol. 2025 Dec 9:S0002-9378(25)00857.
   PubMed        
   
   
8. LEVIN G, Scalia P, Slomovitz B
   Toward Equitable Biomarker-Driven Trials in Gynecologic Oncology Research (Reply to Letter-to-the-Editor).
   Am J Obstet Gynecol. 2025 Dec 5:S0002-9378(25)00899.
   PubMed        
   
   
9. KRASHIN JW, Petersen TR, Espey E
   Patients prioritize choice for postpartum contraception (Reply to Letter-to-the-Editor).
   Am J Obstet Gynecol. 2025 Dec 5:S0002-9378(25)00904.
   PubMed        
   
   
10. BROWN SE, Ravel J, Brotman RM
    Observational Study Design and Intravaginal Product Use in Vaginal Microbiota Research (Reply to Letter-to-the-Editor).
    Am J Obstet Gynecol. 2025 Dec 4:S0002-9378(25)00897.
    PubMed        
    
    
11. TARVONEN M, Riehunkangas T, Tuppurainen V, Jernman R, et al
    Optimal obstetric care reduces neonatal healthcare costs compared with substandard care in hypoxic-ischemic encephalopathy.
    Am J Obstet Gynecol. 2025 Dec 4:S0002-9378(25)00880.
    PubMed         Abstract available
    
    
12. SADOU N, Brousseau E, Auger N
    Race and ancestry in gynecologic oncology research (Letter-to-the-Editor).
    Am J Obstet Gynecol. 2025 Dec 4:S0002-9378(25)00898.
    PubMed        
    
    
13. GAVILLET M, Golshayan D, Baud D
    Immune Tolerance Breakdown in Pregnancy: Transplantation Parallels in Chronic Intervillositis and Villitis of Unknown Etiology (Letter-to-the-Editor).
    Am J Obstet Gynecol. 2025 Dec 3:S0002-9378(25)00881.
    PubMed        
    
    
14. NIETO-CALVACHE AJ, Palacios-Jaraquemada JM, Basanta N, Zea F, et al
    Training in vaginal clamping of uterine arteries increases its safety (Reply to Letter-to-the-Editor).
    Am J Obstet Gynecol. 2025 Dec 3:S0002-9378(25)00875.
    PubMed        
    
    
15. YARAGHI M, Modarresi MS
    Vaginal Clamping of Uterine Arteries (Letter-to-the-Editor).
    Am J Obstet Gynecol. 2025 Dec 3:S0002-9378(25)00874.
    PubMed        
    
    

    
    Am J Surg Pathol

16. PILKINGTON T, Watt C, Dermawan J, Haider A, et al
    Uterine Sarcomas Harbouring Novel FOXO1 Gene Rearrangements: Report of A Case Series.
    Am J Surg Pathol. 2025 Dec 11. doi: 10.1097/PAS.0000000000002494.
    PubMed         Abstract available
    
    

    
    Ann Oncol

17. LEDERMANN JA, Coleman RL
    The PARP inhibitor/Immunotherapy Paradox in Advanced Ovarian Cancer: Positive Endpoints, Perplexing Interpretations.
    Ann Oncol. 2025 Dec 10:S0923-7534(25)06318-5. doi: 10.1016/j.annonc.2025.
    PubMed        
    
    
18. HARTER P, Trillsch F, Okamoto A, Reuss A, et al
    Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer.
    Ann Oncol. 2025 Dec 9:S0923-7534(25)06315-X. doi: 10.1016/j.annonc.2025.
    PubMed         Abstract available
    
    

    
    Aust N Z J Obstet Gynaecol

19. MCLAREN K, Erridge S, Sodergren MH
    A Scoping Systematic Review of Cannabis Use in Endometriosis.
    Aust N Z J Obstet Gynaecol. 2025 Dec 9. doi: 10.1111/ajo.70081.
    PubMed         Abstract available
    
    

    
    BMC Cancer

20. CHEN Q, Dorji JP, Perera SG, Li P, et al
    In vivo inhibition of c-MYC in the metastatic drug-resistant ovarian cancer cells down regulates the c-MYC-PD-L1-PAX8-p21 to achieve therapeutic efficacy.
    BMC Cancer. 2025 Dec 10. doi: 10.1186/s12885-025-15435.
    PubMed         Abstract available
    
    
21. CHEN L, Ji H, Xie Z, Lin Y, et al
    miR-101-3p represses the migratory and invasive abilities of ovarian cancer cells.
    BMC Cancer. 2025;25:1864.
    PubMed         Abstract available
    
    

    
    BMC Urol

22. SHITTU S, Charif B, Fatima S, Aurif F, et al
    Intravesical migration of intrauterine device complicated by multifocal sepsis from ruptured tubo-ovarian abscess and acute appendicitis: a comprehensive clinical case study.
    BMC Urol. 2025 Dec 8. doi: 10.1186/s12894-025-01955.
    PubMed         Abstract available
    
    

    
    Br J Radiol

23. ZHOU Q, Chen L, Zhu C
    The Diagnostic Value of FDG PET/CT in Detecting Ovarian Cancer Recurrence in Patients with Elevated CA-125 Levels: A Systematic Review and Meta-Analysis.
    Br J Radiol. 2025 Dec 8:tqaf291. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Cancer Res

24. WAN T, Deng T, Peng X, Cai G, et al
    Comprehensive Multi-Omic Characterization of Perineural Invasion in Cervical Cancer Reveals Diagnostic Markers, Molecular Drivers, and Therapeutic Strategies.
    Cancer Res. 2025 Dec 11. doi: 10.1158/0008-5472.CAN-25-0149.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

25. HOLLIS RL, Miller A, Lankes HA, Wong KK, et al
    Molecular profiling and tumour biomarker analysis of GOG281/LOGS: a positive late-phase trial of trametinib for recurrent/persistent low grade-serous ovarian cancer.
    Clin Cancer Res. 2025 Dec 11. doi: 10.1158/1078-0432.CCR-25-3042.
    PubMed         Abstract available
    
    

    
    Diagn Cytopathol

26. MA Y, Yu X, Duan X, Huang S, et al
    Detecting FR-? Expression Level in Cytology Effusion Specimens From Ovarian Cancer and Comparing It With Tissue Specimens.
    Diagn Cytopathol. 2025 Dec 13. doi: 10.1002/dc.70067.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

27. KASIUS JC, Kildal W, Vrede SW, Askautrud HA, et al
    Surgical stage in the era of molecular profiling of endometrial cancer.
    Eur J Cancer. 2025;233:116164.
    PubMed         Abstract available
    
    
28. LIN Y, Chen X, Chen W, Sun Y, et al
    Letter to the editor Re: Immunotherapy and PARP inhibitors as first-line treatment in endometrial cancer: A systematic review and network meta-analysis.
    Eur J Cancer. 2025;233:116163.
    PubMed        
    
    

    
    Eur J Obstet Gynecol Reprod Biol

29. TJALMA W
    Discrepancies between ESTRO/ESGO/SIOPE and NCCN guidelines in the management of vaginal cancer: a call for harmonization.
    Eur J Obstet Gynecol Reprod Biol. 2026;316:114824.
    PubMed         Abstract available
    
    
30. ATES C, Dilbaz B, Sacinti KG
    Deciphering the relationship between adenomyosis and the microbiota: a systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2026;316:114823.
    PubMed         Abstract available
    
    
31. KALPINA F, Kumar D, Taj J, Kaleem M, et al
    Efficacy and safety of relugolix therapy for symptomatic uterine fibroids: a systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2025;318:114889.
    PubMed         Abstract available
    
    
32. PIROG M, Chrostowski B, Jach R
    Tubal patency testing in women with polycystic ovary syndrome - is it worth before ovarian induction: Cost-effectiveness analysis.
    Eur J Obstet Gynecol Reprod Biol. 2025;318:114888.
    PubMed         Abstract available
    
    
33. TOUVAL O, Cohen G, Koriat A, Heresco L, et al
    The impact of early amniotomy on delivery outcomes in pregnancies with fetal macrosomia.
    Eur J Obstet Gynecol Reprod Biol. 2025;317:114881.
    PubMed         Abstract available
    
    
34. HONG M, Yang K, Ge H, Tang J, et al
    Prognostic factors for ovarian immature teratoma and significance of alpha-fetoprotein in recurrent cases.
    Eur J Obstet Gynecol Reprod Biol. 2025;317:114882.
    PubMed         Abstract available
    
    
35. SERVIDONI ACP, Castel C, Martin GCC, Armstrong BBS, et al
    Diaphragmatic Endometriosis: Clinical Features and Surgical Outcomes-A Systematic Review and Meta-Analysis.
    Eur J Obstet Gynecol Reprod Biol. 2025;317:114863.
    PubMed        
    
    
36. GUMUSOGLU SB, Schickling BM, Santillan DA, Santillan MK, et al
    Metabolomics reveals pre-eclamptic-protective mechanisms within individuals.
    Eur J Obstet Gynecol Reprod Biol. 2025;317:114877.
    PubMed         Abstract available
    
    
37. TOKUE H, Tokue A, Tsushima Y
    Predicting bleeding risk in placenta accreta spectrum with placenta previa managed by prophylactic balloon occlusion: Utility of cervical venous plexus volume on MRI.
    Eur J Obstet Gynecol Reprod Biol. 2025;317:114849.
    PubMed         Abstract available
    
    
38. TAKAHASHI A, Kitazawa J, Hirata K, Koikawa Y, et al
    Feasibility and perioperative outcomes of vaginal natural orifice transluminal endoscopic hysterectomy regardless of surgeon experience: A comparison with total laparoscopic hysterectomy.
    Eur J Obstet Gynecol Reprod Biol. 2025;317:114864.
    PubMed         Abstract available
    
    

    
    Fertil Steril

39. XU J, Cai Y, Li M, Cheng Z, et al
    Cumulative live birth rates after three sequential single euploid blastocyst transfers in patients with recurrent pregnancy loss.
    Fertil Steril. 2025 Dec 8:S0015-0282(25)02256.
    PubMed        
    
    

    
    Gynecol Endocrinol

40. GU M, Ruan X, Cheng J, Li Y, et al
    Hypoxia-preconditioned hUCMSCs protect frozen-thawed human ovarian tissue by modulating the HIF-1alpha/VEGF pathway.
    Gynecol Endocrinol. 2025;41:2597612.
    PubMed         Abstract available
    
    
41. GU M, Ruan X, Li Y, Jia C, et al
    Effect of oral contraceptive pretreatment on IVF outcomes in women with polycystic ovary syndrome using a long GnRH agonist protocol.
    Gynecol Endocrinol. 2025;41:2594876.
    PubMed         Abstract available
    
    
42. ZHANG F, Wu J, Ge L, Huang Y, et al
    A review of immunometabolic crosstalk in PCOS-related pregnancy loss: mechanisms and emerging therapeutic strategies.
    Gynecol Endocrinol. 2025;41:2600160.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

43. HANSEN J, Suratkal J, Shah SN, Kelley J, et al
    Frailty and body composition as predictors of postoperative outcomes in patients with epithelial ovarian cancer undergoing neoadjuvant chemotherapy.
    Gynecol Oncol. 2025;204:143-149.
    PubMed         Abstract available
    
    
44. WANG Y, Van Nieuwenhuysen E, Revheim ME, Deroose CM, et al
    First experience with intraperitoneal (224)Ra-labeled microparticles after cytoreductive surgery in patients with peritoneal recurrence of platinum-sensitive epithelial ovarian cancer.
    Gynecol Oncol. 2025;204:158-164.
    PubMed         Abstract available
    
    
45. LIM S, Chung YE, Seo JH, Lee Y, et al
    Efficacy and safety of pembrolizumab with or without lenvatinib in recurrent uterine carcinosarcoma: a real-world single-center study.
    Gynecol Oncol. 2025;204:165-173.
    PubMed         Abstract available
    
    
46. MATSUO K, Lee MW, Friedman EL, Erfani H, et al
    Survival assessment of sentinel lymph node biopsy alone without lymphadenectomy for early cervical cancer in real-world data.
    Gynecol Oncol. 2025;204:174-183.
    PubMed         Abstract available
    
    
47. EVANS HE, Firriolo AM, Houweling R, Kelada L, et al
    Evaluating patient perspectives about the acceptability of a novel prognostic gene expression signature for high grade serous ovarian cancer: The OTTA-SPOT study.
    Gynecol Oncol. 2025;204:150-157.
    PubMed         Abstract available
    
    
48. NAKAYAMA J, McGaughey M, Pindzola G, Miller E, et al
    Machine-learning survival models for predicting time to recurrence in epithelial ovarian cancer.
    Gynecol Oncol. 2025;204:184-193.
    PubMed         Abstract available
    
    
49. PEPLINSKI RM, Riordan JD, Schillo JL, Hannan EC, et al
    Co-targeting the PI3K-Akt pathway improves response to MEK inhibition in low-grade serous ovarian cancer cell lines.
    Gynecol Oncol. 2025;204:194-201.
    PubMed         Abstract available
    
    
50. SHAHIN MS, Mathur R, Parthan A, Yerram P, et al
    Comparative outcomes of nab-paclitaxel and paclitaxel in platinum-resistant ovarian cancer (COMPASS).
    Gynecol Oncol. 2025;204:202-209.
    PubMed         Abstract available
    
    
51. HUANG M, McCourt C, Powell MA, Lu KH, et al
    Amplifying SGO'S voice: The impact of the Society of Gynecologic Oncology (SGO) clinical practice committee publications in Gynecologic Oncology.
    Gynecol Oncol. 2025;202:A1-A2.
    PubMed        
    
    
52. FERNANDES I, Sachdeva A, Tavangar F, Lafreniere M, et al
    Evaluating the clinical utility and impact on healthcare utilization of serial troponin T monitoring in gynecologic cancer patients receiving immune checkpoint inhibitors - A single centre experience.
    Gynecol Oncol. 2025;204:210-217.
    PubMed         Abstract available
    
    
53. WASHINGTON C, Pothuri B, Cadoo K, Drew Y, et al
    Updates in US Food and Drug Administration approvals for poly-ADP-ribose polymerase inhibitors in Ovarian Cancer: A society of gynecologic oncology clinical practice review.
    Gynecol Oncol. 2025;204:218-227.
    PubMed         Abstract available
    
    
54. KRAICZY J, Yu B
    Human fallopian tube epithelial organoids with TP53 mutation recapitulate features of serous tubal intraepithelial carcinoma (STIC).
    Gynecol Oncol. 2025;203:198-208.
    PubMed         Abstract available
    
    
55. LU H, Wang Y, Chang L, Liu J, et al
    Treatment patterns and prognosis of patients with locally advanced vulvar cancer: a retrospective cohort study of the SEER database and a Chinese multicenter registry.
    Gynecol Oncol. 2025;203:171-181.
    PubMed         Abstract available
    
    
56. VERMAAS EM, Roling P, Konior KM, Wenzel HHB, et al
    Reconsidering follow-up care in gynaecologic oncology: A scoping review exploring alternative approaches.
    Gynecol Oncol. 2025;203:139-150.
    PubMed         Abstract available
    
    
57. FAN Y, Wang Q, Deng H, Liu Y, et al
    Neoadjuvant chemotherapy modulates mast cell phenotypes and immune infiltration in high-grade serous carcinoma.
    Gynecol Oncol. 2025;203:119-129.
    PubMed         Abstract available
    
    
58. DHANIS J, Pijnenborg JMA, van Laarhoven CJHM, Verlaan S, et al
    The effect of a multimodal prehabilitation programme on preoperative physical fitness and nutritional status of women with gynaecological cancer.
    Gynecol Oncol. 2025;203:1-7.
    PubMed         Abstract available
    
    
59. DRAYER SM, Ogata JD, Cronin S, Tumas J, et al
    Silva pattern-guided proteomics reveals coordinated tumor-stroma remodeling in cervical adenocarcinoma.
    Gynecol Oncol. 2025;202:66-76.
    PubMed         Abstract available
    
    
60. MILMAN T, Hoang L, Hamm J, Chai J, et al
    Real-world utility of Silva pattern in predicting outcomes in cervical adenocarcinoma from a population-based series.
    Gynecol Oncol. 2025;202:53-58.
    PubMed         Abstract available
    
    
61. VAN DEN BORST E, Vanden Broeck D, De Sutter P, Donders G, et al
    EUROArray HPV test accuracy for cervical precancer in self- vs. clinician-collected samples using the VALHUDES protocol.
    Gynecol Oncol. 2025;202:14-23.
    PubMed         Abstract available
    
    
62. LIM JW, Drost L, Fazelzad R, Li Q, et al
    MLH1 promoter hypermethylated endometrial cancer survival outcomes: A systematic review and meta-analysis.
    Gynecol Oncol. 2025;204:242-250.
    PubMed         Abstract available
    
    
63. MAESTA I, Silva VAR, Costa RAA, Carvalho TH, et al
    Home-based treatment of low-risk gestational trophoblastic neoplasia with 8-day methotrexate/folinic acid.
    Gynecol Oncol. 2025;204:235-241.
    PubMed         Abstract available
    
    
64. PATTERSON B, Sinha N, Broaddus E, Stocks S, et al
    Associations between obesity and outcomes in pembrolizumab-treated endometrial cancer.
    Gynecol Oncol. 2025;204:228-234.
    PubMed         Abstract available
    
    

    
    Hum Pathol

65. BUZA N, Sun T, Hui P
    Endometrial Carcinomas - Challenges and Updates on Selected Topics.
    Hum Pathol. 2025 Dec 11:106016. doi: 10.1016/j.humpath.2025.106016.
    PubMed         Abstract available
    
    
66. YANG F, Liu Y, Wang Y, Yang J, et al
    Ovarian GLI1 fusion tumors Mimicking Sex Cord-Stromal Tumors: Clinicopathological and Molecular Characterization of a Five-Case Series.
    Hum Pathol. 2025 Dec 9:106003. doi: 10.1016/j.humpath.2025.106003.
    PubMed         Abstract available
    
    
67. XI Y, He C, Fang X, Yin JC, et al
    Analysis of Discordance between Mismatch Repair and Microsatellite Instability Testing in Endometrial Cancer.
    Hum Pathol. 2025 Dec 8:106004. doi: 10.1016/j.humpath.2025.106004.
    PubMed         Abstract available
    
    

    
    Int J Cancer

68. WIDJAJA AO, Micallef P, Lycke M, Osterlund T, et al
    Detecting TP53 mutations in paired liquid and tissue biopsies from patients with high-grade serous ovarian carcinoma.
    Int J Cancer. 2025 Dec 9. doi: 10.1002/ijc.70277.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

69. NOY-TRAUB NB, Friedman E, Yarza S, Grinblatt E, et al
    Response: Is pathological fetal Doppler cerebroplacental ratio (CPR) associated with adverse delivery outcomes in pregnancies complicated by fetal growth restriction undergoing labor induction? A retrospective cohort study.
    Int J Gynaecol Obstet. 2025 Dec 5. doi: 10.1002/ijgo.70740.
    PubMed        
    
    
70. ERCHICK DJ, Tuddenham S, Kan L, Wu LSF, et al
    Associations between Nugent-bacterial vaginosis and preterm birth and other adverse pregnancy outcomes in rural northwestern Bangladesh.
    Int J Gynaecol Obstet. 2025 Dec 5. doi: 10.1002/ijgo.70691.
    PubMed         Abstract available
    
    
71. BARBERA JP, Mossayebi MH, Khanuja K, Youssef JA, et al
    Idiopathic subglottic stenosis in pregnancy: A systematic review.
    Int J Gynaecol Obstet. 2025 Dec 5. doi: 10.1002/ijgo.70719.
    PubMed         Abstract available
    
    
72. 
    RETRACTION: Role of First-Trimester Three-Dimensional (3D) Power Doppler of Placental Blood Flow And 3D Placental Volume in Early Prediction of Pre-Eclampsia.
    Int J Gynaecol Obstet. 2025 Dec 5. doi: 10.1002/ijgo.70738.
    PubMed         Abstract available
    
    
73. LI Y, Yu Y, Zheng Y, Li Y, et al
    Association between daily caffeine intake and uterine fibroids: Results from NHANES 1999-2006.
    Int J Gynaecol Obstet. 2025 Dec 6. doi: 10.1002/ijgo.70727.
    PubMed         Abstract available
    
    
74. BAHAMONDES L, Pacagnella RC, Marcelino AC, Zulo J, et al
    Hormonal long-acting reversible contraceptives use and potential impact on environment: A mathematical model.
    Int J Gynaecol Obstet. 2025 Dec 8. doi: 10.1002/ijgo.70734.
    PubMed         Abstract available
    
    
75. BAEV OR, Babich DA, Tskhay VB, Bezhenar VF, et al
    Comparison of the sequential use of mifepristone and dinoprostone vaginal insert with dinoprostone vaginal insert as the only method for induction of labor in very unripe cervix: a secondary analysis of a multicenter real-word evidence study.
    Int J Gynaecol Obstet. 2025 Dec 8. doi: 10.1002/ijgo.70726.
    PubMed         Abstract available
    
    
76. MATYLEVICH OP, Shelkovich SY, Balshakova AG, Yaumenenka AA, et al
    Epidemiological trends in uterine corpus malignancies in Belarus: A 30-year analysis (1993-2022).
    Int J Gynaecol Obstet. 2025 Dec 10. doi: 10.1002/ijgo.70743.
    PubMed         Abstract available
    
    
77. BAKAR S, Arpa M, Kuruca N, Senturk S, et al
    Gremlin-1 is associated with obesity but not polycystic ovary syndrome: Insights from a body mass index-matched analysis of bone morphogenetic protein pathway components, a cross-sectional study.
    Int J Gynaecol Obstet. 2025 Dec 10. doi: 10.1002/ijgo.70725.
    PubMed         Abstract available
    
    
78. AINSWORTH AJ, Smith CY, Neblett MF 2nd, Rocca WA, et al
    Risk of subsequent abdominopelvic surgery in women undergoing hysterectomy with ovarian conservation: A population-based cohort study.
    Int J Gynaecol Obstet. 2025 Dec 12. doi: 10.1002/ijgo.70745.
    PubMed         Abstract available
    
    
79. MANISHA M, Singh P, Yadav G, Gothwal M, et al
    Genotype-specific Human Papillomavirus patterns and their implications across the cervical cancer spectrum: A cross-sectional study from Western India.
    Int J Gynaecol Obstet. 2025 Dec 12. doi: 10.1002/ijgo.70730.
    PubMed         Abstract available
    
    

    
    Int J Oncol

80. WANG F, Xu X, Guan B, Li X, et al
    Regulation and reversal of paclitaxel resistance via the STAT1?mediated apoptotic pathway in ovarian cancer.
    Int J Oncol. 2026;68:19.
    PubMed         Abstract available
    
    
81. YE H, Zhang Y, Geng L, Li Z, et al
    [Retracted] Cdc42 expression in cervical cancer and its effects on cervical tumor invasion and migration.
    Int J Oncol. 2026;68:20.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

82. MIYAKE A, Iida M, Harada S, Sugiyama D, et al
    Longitudinal study of plasma metabolites during menopause and their associations with later onset of metabolic syndrome.
    J Clin Endocrinol Metab. 2025 Dec 13:dgaf666. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    JAMA

83. PANT S
    Strides in Cervical Cancer Elimination.
    JAMA. 2025 Dec 12. doi: 10.1001/jama.2025.20021.
    PubMed        
    
    
84. PANT S
    FDA Removes Some Warnings on Menopause Hormone Therapies.
    JAMA. 2025 Dec 5. doi: 10.1001/jama.2025.20011.
    PubMed        
    
    
85. ANDERER S
    WHO Releases First Global Guidelines for Diabetes Management in Pregnancy.
    JAMA. 2025 Dec 5. doi: 10.1001/jama.2025.20013.
    PubMed        
    
    

    
    Lancet

86. GOADSBY J, Syngelaki A, Magee LA, von Dadelszen P, et al
    Scheduled birth at term for the prevention of pre-eclampsia (PREVENT-PE): an open-label randomised controlled trial.
    Lancet. 2025 Dec 4:S0140-6736(25)01207-3. doi: 10.1016/S0140-6736(25)01207.
    PubMed         Abstract available
    
    
87. TONG S, Cluver CA, Walker SP
    Reducing term pre-eclampsia by 30%: is it possible?
    Lancet. 2025 Dec 4:S0140-6736(25)01672-1. doi: 10.1016/S0140-6736(25)01672.
    PubMed        
    
    

    
    Obstet Gynecol

88. ROWE JC 4TH, Scaglione M, Ma'ayeh M, Saade G, et al
    Diagnosis and Management of Euglycemic Diabetic Ketoacidosis in Pregnancy.
    Obstet Gynecol. 2025 Dec 11. doi: 10.1097/AOG.0000000000006143.
    PubMed         Abstract available
    
    
89. CIESLA AA, Lazariu V, Watts JA, Vazquez-Benitez G, et al
    Effectiveness of 2023-2024 Coronavirus Disease 2019 (COVID-19) Vaccines in Pregnant Women.
    Obstet Gynecol. 2025 Dec 11. doi: 10.1097/AOG.0000000000006145.
    PubMed         Abstract available
    
    
90. QIN J, Martinez G, Holt HK, Gopalani SV, et al
    Preferences Among U.S. Women for Cervical Cancer Screening with Self-Collected Specimens for Human Papillomavirus Testing.
    Obstet Gynecol. 2025 Dec 11. doi: 10.1097/AOG.0000000000006147.
    PubMed         Abstract available
    
    
91. OLULORO A, Pike M, Luu T, Moore A, et al
    Association Between Comorbidity and Clinical Trial Enrollment for Patients With Uterine Cancer.
    Obstet Gynecol. 2025 Dec 4. doi: 10.1097/AOG.0000000000006135.
    PubMed         Abstract available
    
    
92. AZUBUIKE C, Deng A, Goodin A
    Nationwide Prevalence of Cannabidiol Use in Pregnancy and in Women of Reproductive Age.
    Obstet Gynecol. 2025 Dec 4. doi: 10.1097/AOG.0000000000006140.
    PubMed         Abstract available
    
    
93. ERDEN M, Rehman S, Oh C, Schwartz BM, et al
    Fertility-Sparing Treatments in Patient With Gynecologic Cancers.
    Obstet Gynecol. 2025 Dec 4. doi: 10.1097/AOG.0000000000006141.
    PubMed         Abstract available
    
    

    
    Oncogene

94. LI Q, Zhang S, Wang M, Yi Q, et al
    Correction: Activated MAFB in ovarian cancer promotes cytoskeletal remodeling and immune microenvironment suppression by interfering with m6A modifications through WTAP competition.
    Oncogene. 2025 Dec 5. doi: 10.1038/s41388-025-03656.
    PubMed        
    
    

    
    PLoS Med

95. DOKRAS A, Coutifaris C, Remaley AT, Mehta NN, et al
    Impact of combined hormonal contraceptives and metformin on metabolic syndrome in women with hyperandrogenic polycystic ovary syndrome and obesity: The COMET-PCOS randomized clinical trial.
    PLoS Med. 2025;22:e1004662.
    PubMed         Abstract available
    
    

    
    PLoS One

96. KOLCU SA, Kara E, Yildiz E, Cetin A, et al
    Levonorgestrel-releasing intrauterine device treatment in heavy menstrual bleeding: Correlation with endometrial pathology and quality of life.
    PLoS One. 2025;20:e0338480.
    PubMed         Abstract available
    
    
97. MENGISTIE BA, Aragaw GM, Anteneh TA, Wondie KY, et al
    Prevalence and determinants of precancerous cervical lesions among women screened for cervical cancer in Africa: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0338484.
    PubMed         Abstract available
    
    
98. NESSA A, Ferdouse J, Khatoon F, Sonia AA, et al
    High-risk human papillomavirus genotypes among women of hill districts in Bangladesh.
    PLoS One. 2025;20:e0338092.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.